Literature DB >> 3436338

Binding of non-steroid anti-inflammatory drugs and warfarin to liver tissue of rabbits in vitro.

C Tesseromatis1, B Fichtl, H Kurz.   

Abstract

Liver slices (10mm 0.1mm thickness) were incubated at 37 degrees C in drug solutions up to 360 min. The drugs were dissolved in Ringer solution of pH 7.0. After 60, 180, 240 and 360 min each drug concentration was determined in the incubation fluid. For all drugs tested equilibrium was obtained after 240 min. The amount of drug taken up by the slices was calculated from the difference to initial concentration. In parallel, samples of the slices were homogenized together with their incubation fluids after the same incubation intervals. The free concentration was determined by ultrafiltration. For warfarin and several non-steroid anti-inflammatory drugs (NSAID), i.e. acetylsalicylic acid, ibuprofen, ketoprofen and oxyphenbutazone, there was no difference between the free drug concentrations in the homogenized and in non-homogenized samples. This suggests that the binding of these drugs to liver tissue was not altered by homogenization. Further was studied whether NSAIDS interfere with binding of warfarin to liver tissue. Acetylsalicylic acid, flurbiprofen, ibuprofen, ketoprofen, oxyphenbutazone and proquazon markedly increased the free concentration of warfarin both in liver slices and homogenates (p less than 0.01). The extent of displacement did not differ between slices and homogenates.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436338     DOI: 10.1007/BF03189892

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  19 in total

1.  The colorimetric micro-determination of long-chain fatty acids.

Authors:  W G Duncombe
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Critical evaluation of use of effective protein fractions in developing pharmacokinetic models for drug distribution.

Authors:  D Shen; M Gibaldi
Journal:  J Pharm Sci       Date:  1974-11       Impact factor: 3.534

3.  [Permeation of poisons in the liver; properties of the cellular membrane].

Authors:  H Kurz
Journal:  Naunyn Schmiedebergs Arch Pharmakol Exp Pathol       Date:  1966

4.  The accumulation and distribution of dicumarol in rat liver slices.

Authors:  W D Wosilait
Journal:  Biochem Pharmacol       Date:  1968-03       Impact factor: 5.858

5.  Pharmacokinetic analysis of potentiating effect of phenylbutazone on anticoagulant action of warfarin in man.

Authors:  R A O'Reilly; G Levy
Journal:  J Pharm Sci       Date:  1970-09       Impact factor: 3.534

6.  Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration.

Authors:  H Kurz; H Trunk; B Weitz
Journal:  Arzneimittelforschung       Date:  1977-07

7.  The effect of hepatic blood flow on the hepatic removal rate of oxyphenbutazone in the dog.

Authors:  T L Whitsett; P G Dayton; J L McNay
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

8.  Comparative pharmacokinetics of coumarin anticoagulants XXXII: Interindividual differences in binding of warfarin and dicumarol in rat liver and implications for physiological pharmacokinetic modeling.

Authors:  G Levy; C M Lai; A Yacobi
Journal:  J Pharm Sci       Date:  1978-02       Impact factor: 3.534

9.  Determination of ketoprofen by direct injection of deproteinized body fluids into a high-pressure liquid chromatographic system.

Authors:  R Ballerini; A Cambi; P Del Soldato; F Melani; A Meli
Journal:  J Pharm Sci       Date:  1979-03       Impact factor: 3.534

10.  A simple and sensitive colorimetric determination of ibuprofen from plasma and urine in dogs after dosing.

Authors:  H Fujise
Journal:  Nihon Juigaku Zasshi       Date:  1977-12
View more
  8 in total

1.  Modifications of clonidine binding to rabbit liver protein under the influence of non-steroid-anti-inflammatory drugs in vitro.

Authors:  C Tesserommatis; T Saranteas; E Chatzijanni; S Anagnostopoulou; A Cotsiou; C Chatzi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Jul-Sep       Impact factor: 2.441

Review 2.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

3.  Adjuvant arthritis-induced changes on ampicillin binding in serum and tissues under the influence of non-steroidal anti-inflammatory drugs in rats.

Authors:  E Tigka; I Daskala; G Rallis; S Anagnostopoulou; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Oct-Dec       Impact factor: 2.441

4.  In vitro binding of lidocaine to liver tissue under the influence of propranolol: another mechanism of interaction?

Authors:  C Tesseromatis; A Kotsiou; M Tsagataki; E Tigka; J Vovou; A Alevizou; C Perisanidis; T Saranteas; D Karakitsos; A Karabinis; G Kostopanagiotou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Oct-Dec       Impact factor: 2.441

Review 5.  The role of the protein-binding on the mode of drug action as well the interactions with other drugs.

Authors:  Christine Tesseromatis; Anastasia Alevizou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

6.  H3 Propranolol serum levels following lidocaine administration in rats with CCL4 induced liver damage.

Authors:  A Kotsiou; M Tsamouri; S Anagnostopoulou; M Tzivras; E Vairactaris; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

7.  Anticoagulant-induced changes on antibiotic concentrations in the serum and bones.

Authors:  A Kotsiou; E Diamanti; A Potamianou; H Parara; J Vovou; C Perisanidis; C Tes; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Jul-Sep       Impact factor: 2.441

8.  Clonidine changes lidocaine free concentrations in rat myocardium without affecting heart function measured by echocardiography.

Authors:  E Tigka; A Kotsiou; T Saranteas; J Mourouzis; G Kostopanagiotou; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2009 Jul-Sep       Impact factor: 2.569

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.